BR112013014081A2 - gel polivalente para secura vaginal com efeito direto e retardado - Google Patents

gel polivalente para secura vaginal com efeito direto e retardado

Info

Publication number
BR112013014081A2
BR112013014081A2 BR112013014081A BR112013014081A BR112013014081A2 BR 112013014081 A2 BR112013014081 A2 BR 112013014081A2 BR 112013014081 A BR112013014081 A BR 112013014081A BR 112013014081 A BR112013014081 A BR 112013014081A BR 112013014081 A2 BR112013014081 A2 BR 112013014081A2
Authority
BR
Brazil
Prior art keywords
delayed
direct effect
vaginal dryness
multipurpose
gel
Prior art date
Application number
BR112013014081A
Other languages
English (en)
Other versions
BR112013014081B1 (pt
Inventor
Alberto Bartorelli
Maria Rosa Gobbi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of BR112013014081A2 publication Critical patent/BR112013014081A2/pt
Publication of BR112013014081B1 publication Critical patent/BR112013014081B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112013014081-0A 2010-12-09 2011-12-02 Composições vaginais tópicas na forma de gel BR112013014081B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2010A002260A IT1405998B1 (it) 2010-12-09 2010-12-09 Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
ITMI2010A002260 2010-12-09
PCT/EP2011/071612 WO2012076409A1 (en) 2010-12-09 2011-12-02 Multipurpose gel for vaginal dryness with direct and delayed effect

Publications (2)

Publication Number Publication Date
BR112013014081A2 true BR112013014081A2 (pt) 2016-09-20
BR112013014081B1 BR112013014081B1 (pt) 2020-03-17

Family

ID=43736916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013014081-0A BR112013014081B1 (pt) 2010-12-09 2011-12-02 Composições vaginais tópicas na forma de gel

Country Status (26)

Country Link
US (1) US9248151B2 (pt)
EP (1) EP2648739B1 (pt)
JP (1) JP6120774B2 (pt)
CN (1) CN103338778B (pt)
AU (1) AU2011340757B2 (pt)
BR (1) BR112013014081B1 (pt)
CA (1) CA2820403C (pt)
CO (1) CO6781483A2 (pt)
CY (1) CY1118832T1 (pt)
DK (1) DK2648739T3 (pt)
EA (1) EA026198B1 (pt)
ES (1) ES2624766T3 (pt)
HR (1) HRP20170663T1 (pt)
HU (1) HUE033257T2 (pt)
IL (1) IL226764A (pt)
IT (1) IT1405998B1 (pt)
LT (1) LT2648739T (pt)
ME (1) ME02665B (pt)
MX (1) MX341572B (pt)
MY (1) MY160610A (pt)
PL (1) PL2648739T3 (pt)
PT (1) PT2648739T (pt)
RS (1) RS55910B1 (pt)
SI (1) SI2648739T1 (pt)
WO (1) WO2012076409A1 (pt)
ZA (1) ZA201304147B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6139562B2 (ja) 2011-12-30 2017-05-31 イノメッド ソシエテ アノニム 成長因子、サイトカイン、抗菌/抗ウイルス因子、幹細胞刺激因子、補体タンパク質c3a/c4a、免疫グロブリンおよび走化性因子の組合せ
EP2815757A1 (en) * 2013-06-17 2014-12-24 Hestia Investments Composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa
CN105030872A (zh) * 2015-07-30 2015-11-11 太阳树(厦门)生物工程有限公司 一种玛咖提取物的提取工艺
ITUB20155902A1 (it) 2015-11-25 2017-05-25 Nathura S P A Composizione farmaceutica cicatrizzante per uso topico
NL2017656B1 (nl) * 2016-10-21 2018-04-30 Johan Wagenaar Louis Samenstelling voor slijmvliesherstel
CN107693842B (zh) * 2017-12-05 2020-05-05 湖北美尔丽生物科技有限公司 一种医用耐水凝胶及其制备方法
IT201800002990A1 (it) * 2018-02-23 2019-08-23 Biomedical Res Srl Composizione a base di una miscela di fattori biologici isolata dal colostro e oli vegetali ozonizzati per l’uso nel trattamento di vaginiti e vaginosi
EP3787659A1 (en) * 2018-05-04 2021-03-10 The Procter & Gamble Company Compositions and methods for treating vaginal atrophy
CN112088010A (zh) * 2018-05-04 2020-12-15 宝洁公司 用于治疗***干燥的组合物和方法
EP3603626A1 (en) * 2018-07-31 2020-02-05 Mucosa Innovations, S.L. Composition for use in the prevention and/or treatment of the genitourinary mucosa
RS58997B1 (sr) 2018-09-14 2019-08-30 Fazlagic Amira Dr Kompozicija protiv starenja kože intimne regije
CN111744005B (zh) * 2020-06-24 2024-04-26 黑龙江天龙药业有限公司 一种女性下生殖道粘膜保护、再生喷剂及其制备方法
CN112999335A (zh) * 2021-02-26 2021-06-22 王利琼 一种用于女性***预防与治疗各种妇科炎症、抗hpv的缓释水凝胶的制备方法
CA3215893A1 (en) * 2021-04-23 2022-10-27 Marcel Veeger Disinfectant and use thereof
CN114588252A (zh) * 2022-04-08 2022-06-07 暨南大学附属第一医院(广州华侨医院) 一种用于缓解***萎缩和干燥症的组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177223B1 (en) * 1984-09-24 1990-02-28 Michael Mezei Pharmaceutical multi-phase composition
US20030215506A1 (en) * 2002-05-17 2003-11-20 Kuhrts Eric H Methods and compositions for enhancement of creatine transport
CA2521855A1 (en) 2003-04-09 2004-10-21 Dolhay Klinika Egeszsegugyi Kft. Feminine hygiene composition comprising an equid milk extract
CN1557340A (zh) * 2004-01-15 2004-12-29 高春平 生长因子和免疫球蛋白制剂
EP1802287A2 (en) * 2004-09-27 2007-07-04 Sigmoid Biotechnologies Limited Minicapsule formulations
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
DK1879908T3 (da) * 2005-05-10 2014-03-31 Murray Goulburn Coop Co Ltd Immunoglobulinfraktion og fremgangsmåde hertil
KR100509681B1 (ko) * 2005-05-27 2005-08-23 주식회사 렉스진바이오텍 포유동물의 초유 또는 유즙 유래의 유청분리분획을포함하는 성장 촉진용 식품 조성물
ITMI20051777A1 (it) * 2005-09-23 2007-03-24 Pharmaproducts Uk Ltd Composizioni a base di colostro per il trattamento della secchezza vaginale
CA2838111C (en) * 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
DK2392343T3 (en) 2006-07-03 2019-01-28 Perraudin Jean Paul Antimicrobial compositions comprising hypohalite and / or hypothiocyanite and applications thereof
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
DK2268669T3 (da) * 2008-03-13 2017-11-20 Immuron Ltd Bovin kolostrum omfattende antistoffer mod insulin til behandling af stofskifteforstyrrelsessygdomme
EP2280999B1 (en) * 2008-05-15 2017-09-06 Biosys Health Inc. Process for producing milk fractions rich in secretory immunoglobulins
IT1392471B1 (it) * 2008-11-25 2012-03-09 Pharmafilm S R L Collutorio in forma di sospensione stabile comprendente microsfere che incorporano un principio attivo.

Also Published As

Publication number Publication date
SI2648739T1 (sl) 2017-05-31
MX2013006406A (es) 2014-01-31
HUE033257T2 (hu) 2017-11-28
AU2011340757B2 (en) 2016-10-27
IT1405998B1 (it) 2014-02-06
US9248151B2 (en) 2016-02-02
PL2648739T3 (pl) 2017-08-31
DK2648739T3 (en) 2017-05-01
US20140322329A1 (en) 2014-10-30
EP2648739B1 (en) 2017-02-15
CO6781483A2 (es) 2013-10-31
JP6120774B2 (ja) 2017-04-26
EA026198B1 (ru) 2017-03-31
BR112013014081B1 (pt) 2020-03-17
HRP20170663T1 (hr) 2017-06-30
RS55910B1 (sr) 2017-09-29
EA201390663A1 (ru) 2013-11-29
CN103338778B (zh) 2018-02-02
CA2820403A1 (en) 2012-06-14
WO2012076409A1 (en) 2012-06-14
LT2648739T (lt) 2017-04-25
ITMI20102260A1 (it) 2012-06-10
MY160610A (en) 2017-03-15
ES2624766T3 (es) 2017-07-17
CA2820403C (en) 2018-05-01
JP2013544858A (ja) 2013-12-19
EP2648739A1 (en) 2013-10-16
AU2011340757A1 (en) 2013-07-04
CN103338778A (zh) 2013-10-02
ME02665B (me) 2017-06-20
MX341572B (es) 2016-08-25
PT2648739T (pt) 2017-05-23
CY1118832T1 (el) 2018-01-10
IL226764A (en) 2016-12-29
ZA201304147B (en) 2014-08-27

Similar Documents

Publication Publication Date Title
BR112013014081A2 (pt) gel polivalente para secura vaginal com efeito direto e retardado
DK2717999T3 (da) Varme- og fugtveksler
BR112013008410A2 (pt) sistema para uso em reparação tecidual
ES2585388T5 (es) Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
ES2638522T8 (es) Procedimientos para detectar cáncer
BR112013003304A2 (pt) composição lubrificante e composição lubrificante para uso em condições externas
BR112013009715A2 (pt) aparelho e método para carregar baterias rapidamente
BRDI7005255S (pt) Configuração aplicada em aplicador para maquiagem
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
BR112013009578A2 (pt) composição tópica em gel e método
BR112013012690A2 (pt) forro para tetina e respectiva tetina
BR112014012533A2 (pt) método de fertilização in vitro com atraso de transferência de embrião e uso de células mononucleares de sangue periférico
IT1398438B1 (it) Dispositivo di premacinazione e relativo procedimento
BR112013009577A2 (pt) composição de gel tópico e método
BRDI7005254S (pt) Configuração aplicada em aplicador para maquiagem
BRPI1015442A2 (pt) monômeros e macrômeros para formar hidrogéis
BR112012016685A2 (pt) dispositivo para engate de reboque
BRPI1011278A2 (pt) sonda para inseminação artificial, em especial de porcos
BR112013012843A2 (pt) composições e métodos para o suprimento de nutriente
ES2629891T8 (es) Dispositivo y procedimiento para la transferencia de monedas
ES1071902Y (es) Mecanismo de termosoldadura y precorte
BR112013013441A2 (pt) composição de adesivo-engomadura e métodos relacionados
ES1074944Y (es) Envase monodosis para dentifricos y similares
FR2966365B1 (fr) Composition de gel topique

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/12/2011, OBSERVADAS AS CONDICOES LEGAIS.